๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer

โœ Scribed by Tianqian Zhang; Dorothee Herlyn

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
571 KB
Volume
58
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Active specific immunotherapy and immuno
Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer
โœ Ariel Hollinshead ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 629 KB

## Abstract In this seminar, we describe 1) the immunogen TAA used for lung cancer immunotherapy and the immunogen TAA used for colon cancer immunotherapy, 2) the methods used in the administration of these immunogens in clinical trials of specific active TAA immunotherapy, 3) the results of clinic

A Phase III randomized study of interleu
A Phase III randomized study of interleukin-2 lymphokine-activated killer cell immunotherapy combined with chemotherapy or radiotherapy after curative or noncurative resection of primary lung carcinoma
โœ Hideki Kimura; Yutaka Yamaguchi ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 141 KB ๐Ÿ‘ 2 views

## Background: Adoptive immunotherapy with interleukin-2 (il-2) and lymphokine-activated killer (lak) cells has resulted in response among some patients with advanced malignant disease. however, the relative therapeutic benefit of adoptive immunotherapy as an adjuvant to surgery has not been determ